Details
Stereochemistry | RACEMIC |
Molecular Formula | C13H18O2 |
Molecular Weight | 206.2808 |
Optical Activity | ( + / - ) |
Defined Stereocenters | 0 / 1 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CC(C)CC1=CC=C(C=C1)C(C)C(O)=O
InChI
InChIKey=HEFNNWSXXWATRW-UHFFFAOYSA-N
InChI=1S/C13H18O2/c1-9(2)8-11-4-6-12(7-5-11)10(3)13(14)15/h4-7,9-10H,8H2,1-3H3,(H,14,15)
Molecular Formula | C13H18O2 |
Molecular Weight | 206.2808 |
Charge | 0 |
Count |
|
Stereochemistry | RACEMIC |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 1 |
E/Z Centers | 0 |
Optical Activity | ( + / - ) |
Approval Year
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 16:13:11 UTC 2023
by
admin
on
Fri Dec 15 16:13:11 UTC 2023
|
Record UNII |
WK2XYI10QM
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Brand Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Brand Name | English | ||
|
Brand Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Brand Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
WHO-ATC |
N02AJ19
Created by
admin on Fri Dec 15 16:13:11 UTC 2023 , Edited by admin on Fri Dec 15 16:13:11 UTC 2023
|
||
|
LIVERTOX |
NBK547845
Created by
admin on Fri Dec 15 16:13:11 UTC 2023 , Edited by admin on Fri Dec 15 16:13:11 UTC 2023
|
||
|
NDF-RT |
N0000000160
Created by
admin on Fri Dec 15 16:13:11 UTC 2023 , Edited by admin on Fri Dec 15 16:13:11 UTC 2023
|
||
|
WHO-VATC |
QM02AA13
Created by
admin on Fri Dec 15 16:13:11 UTC 2023 , Edited by admin on Fri Dec 15 16:13:11 UTC 2023
|
||
|
WHO-ATC |
G02CC01
Created by
admin on Fri Dec 15 16:13:11 UTC 2023 , Edited by admin on Fri Dec 15 16:13:11 UTC 2023
|
||
|
WHO-ESSENTIAL MEDICINES LIST |
7.1
Created by
admin on Fri Dec 15 16:13:11 UTC 2023 , Edited by admin on Fri Dec 15 16:13:11 UTC 2023
|
||
|
FDA ORPHAN DRUG |
100896
Created by
admin on Fri Dec 15 16:13:11 UTC 2023 , Edited by admin on Fri Dec 15 16:13:11 UTC 2023
|
||
|
WHO-ESSENTIAL MEDICINES LIST |
8.4
Created by
admin on Fri Dec 15 16:13:11 UTC 2023 , Edited by admin on Fri Dec 15 16:13:11 UTC 2023
|
||
|
WHO-ATC |
M01AE51
Created by
admin on Fri Dec 15 16:13:11 UTC 2023 , Edited by admin on Fri Dec 15 16:13:11 UTC 2023
|
||
|
NDF-RT |
N0000175721
Created by
admin on Fri Dec 15 16:13:11 UTC 2023 , Edited by admin on Fri Dec 15 16:13:11 UTC 2023
|
||
|
EU-Orphan Drug |
EU/3/01/020
Created by
admin on Fri Dec 15 16:13:11 UTC 2023 , Edited by admin on Fri Dec 15 16:13:11 UTC 2023
|
||
|
WHO-VATC |
QM01AE51
Created by
admin on Fri Dec 15 16:13:11 UTC 2023 , Edited by admin on Fri Dec 15 16:13:11 UTC 2023
|
||
|
WHO-VATC |
QM01AE01
Created by
admin on Fri Dec 15 16:13:11 UTC 2023 , Edited by admin on Fri Dec 15 16:13:11 UTC 2023
|
||
|
WHO-VATC |
QG02CC01
Created by
admin on Fri Dec 15 16:13:11 UTC 2023 , Edited by admin on Fri Dec 15 16:13:11 UTC 2023
|
||
|
NDF-RT |
N0000175722
Created by
admin on Fri Dec 15 16:13:11 UTC 2023 , Edited by admin on Fri Dec 15 16:13:11 UTC 2023
|
||
|
NCI_THESAURUS |
C1323
Created by
admin on Fri Dec 15 16:13:11 UTC 2023 , Edited by admin on Fri Dec 15 16:13:11 UTC 2023
|
||
|
WHO-ATC |
R02AX02
Created by
admin on Fri Dec 15 16:13:11 UTC 2023 , Edited by admin on Fri Dec 15 16:13:11 UTC 2023
|
||
|
WHO-ATC |
M01AE01
Created by
admin on Fri Dec 15 16:13:11 UTC 2023 , Edited by admin on Fri Dec 15 16:13:11 UTC 2023
|
||
|
WHO-ATC |
N02AJ08
Created by
admin on Fri Dec 15 16:13:11 UTC 2023 , Edited by admin on Fri Dec 15 16:13:11 UTC 2023
|
||
|
WHO-ATC |
C01EB16
Created by
admin on Fri Dec 15 16:13:11 UTC 2023 , Edited by admin on Fri Dec 15 16:13:11 UTC 2023
|
||
|
EMA ASSESSMENT REPORTS |
PEDEA (AUTHORIZED: DUCTUS ATERIOSUS, PATENT)
Created by
admin on Fri Dec 15 16:13:11 UTC 2023 , Edited by admin on Fri Dec 15 16:13:11 UTC 2023
|
||
|
WHO-ESSENTIAL MEDICINES LIST |
29
Created by
admin on Fri Dec 15 16:13:11 UTC 2023 , Edited by admin on Fri Dec 15 16:13:11 UTC 2023
|
||
|
WHO-ESSENTIAL MEDICINES LIST |
2.1
Created by
admin on Fri Dec 15 16:13:11 UTC 2023 , Edited by admin on Fri Dec 15 16:13:11 UTC 2023
|
||
|
WHO-ATC |
M02AA13
Created by
admin on Fri Dec 15 16:13:11 UTC 2023 , Edited by admin on Fri Dec 15 16:13:11 UTC 2023
|
||
|
WHO-VATC |
QC01EB16
Created by
admin on Fri Dec 15 16:13:11 UTC 2023 , Edited by admin on Fri Dec 15 16:13:11 UTC 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
m6189
Created by
admin on Fri Dec 15 16:13:11 UTC 2023 , Edited by admin on Fri Dec 15 16:13:11 UTC 2023
|
PRIMARY | Merck Index | ||
|
WK2XYI10QM
Created by
admin on Fri Dec 15 16:13:11 UTC 2023 , Edited by admin on Fri Dec 15 16:13:11 UTC 2023
|
PRIMARY | |||
|
CHEMBL521
Created by
admin on Fri Dec 15 16:13:11 UTC 2023 , Edited by admin on Fri Dec 15 16:13:11 UTC 2023
|
PRIMARY | |||
|
C561
Created by
admin on Fri Dec 15 16:13:11 UTC 2023 , Edited by admin on Fri Dec 15 16:13:11 UTC 2023
|
PRIMARY | |||
|
WK2XYI10QM
Created by
admin on Fri Dec 15 16:13:11 UTC 2023 , Edited by admin on Fri Dec 15 16:13:11 UTC 2023
|
PRIMARY | |||
|
1335508
Created by
admin on Fri Dec 15 16:13:11 UTC 2023 , Edited by admin on Fri Dec 15 16:13:11 UTC 2023
|
PRIMARY | |||
|
15687-27-1
Created by
admin on Fri Dec 15 16:13:11 UTC 2023 , Edited by admin on Fri Dec 15 16:13:11 UTC 2023
|
PRIMARY | |||
|
D007052
Created by
admin on Fri Dec 15 16:13:11 UTC 2023 , Edited by admin on Fri Dec 15 16:13:11 UTC 2023
|
PRIMARY | |||
|
132922
Created by
admin on Fri Dec 15 16:13:11 UTC 2023 , Edited by admin on Fri Dec 15 16:13:11 UTC 2023
|
PRIMARY | |||
|
58560-75-1
Created by
admin on Fri Dec 15 16:13:11 UTC 2023 , Edited by admin on Fri Dec 15 16:13:11 UTC 2023
|
SUPERSEDED | |||
|
DB01050
Created by
admin on Fri Dec 15 16:13:11 UTC 2023 , Edited by admin on Fri Dec 15 16:13:11 UTC 2023
|
PRIMARY | |||
|
2118
Created by
admin on Fri Dec 15 16:13:11 UTC 2023 , Edited by admin on Fri Dec 15 16:13:11 UTC 2023
|
PRIMARY | |||
|
1407
Created by
admin on Fri Dec 15 16:13:11 UTC 2023 , Edited by admin on Fri Dec 15 16:13:11 UTC 2023
|
PRIMARY | |||
|
5640
Created by
admin on Fri Dec 15 16:13:11 UTC 2023 , Edited by admin on Fri Dec 15 16:13:11 UTC 2023
|
PRIMARY | RxNorm | ||
|
2713
Created by
admin on Fri Dec 15 16:13:11 UTC 2023 , Edited by admin on Fri Dec 15 16:13:11 UTC 2023
|
PRIMARY | |||
|
5855
Created by
admin on Fri Dec 15 16:13:11 UTC 2023 , Edited by admin on Fri Dec 15 16:13:11 UTC 2023
|
PRIMARY | |||
|
239-784-6
Created by
admin on Fri Dec 15 16:13:11 UTC 2023 , Edited by admin on Fri Dec 15 16:13:11 UTC 2023
|
PRIMARY | |||
|
139466-08-3
Created by
admin on Fri Dec 15 16:13:11 UTC 2023 , Edited by admin on Fri Dec 15 16:13:11 UTC 2023
|
SUPERSEDED | |||
|
DTXSID5020732
Created by
admin on Fri Dec 15 16:13:11 UTC 2023 , Edited by admin on Fri Dec 15 16:13:11 UTC 2023
|
PRIMARY | |||
|
256857
Created by
admin on Fri Dec 15 16:13:11 UTC 2023 , Edited by admin on Fri Dec 15 16:13:11 UTC 2023
|
PRIMARY | |||
|
3099
Created by
admin on Fri Dec 15 16:13:11 UTC 2023 , Edited by admin on Fri Dec 15 16:13:11 UTC 2023
|
PRIMARY | |||
|
IBUPROFEN
Created by
admin on Fri Dec 15 16:13:11 UTC 2023 , Edited by admin on Fri Dec 15 16:13:11 UTC 2023
|
PRIMARY | Description: Colourless crystals or a white, crystalline powder; odour, characteristic. Solubility: Practically insoluble in water; soluble in 1.5 parts of ethanol (~750 g/l) TS, in 2 parts of ether R and in 1.5 parts of acetone R. Category: Analgesic; anti-inflammatory. Storage: Ibuprofen should be kept in a well-closed container. Definition: Ibuprofen contains not less than 98.5% and not more than 100.5% of C13H18O2, calculated with reference to the dried substance. | ||
|
100000090365
Created by
admin on Fri Dec 15 16:13:11 UTC 2023 , Edited by admin on Fri Dec 15 16:13:11 UTC 2023
|
PRIMARY | |||
|
3672
Created by
admin on Fri Dec 15 16:13:11 UTC 2023 , Edited by admin on Fri Dec 15 16:13:11 UTC 2023
|
PRIMARY | |||
|
43415
Created by
admin on Fri Dec 15 16:13:11 UTC 2023 , Edited by admin on Fri Dec 15 16:13:11 UTC 2023
|
PRIMARY | |||
|
Ibuprofen
Created by
admin on Fri Dec 15 16:13:11 UTC 2023 , Edited by admin on Fri Dec 15 16:13:11 UTC 2023
|
PRIMARY | |||
|
IBUPROFEN
Created by
admin on Fri Dec 15 16:13:11 UTC 2023 , Edited by admin on Fri Dec 15 16:13:11 UTC 2023
|
PRIMARY | |||
|
SUB08098MIG
Created by
admin on Fri Dec 15 16:13:11 UTC 2023 , Edited by admin on Fri Dec 15 16:13:11 UTC 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
SALT/SOLVATE -> PARENT | |||
|
METABOLIC ENZYME -> SUBSTRATE | |||
|
SALT/SOLVATE -> PARENT | |||
|
TRANSPORTER -> INHIBITOR | |||
|
SALT/SOLVATE -> PARENT | |||
|
TRANSPORTER -> INHIBITOR | |||
|
SALT/SOLVATE -> PARENT | |||
|
TRANSPORTER -> INHIBITOR | |||
|
TRANSPORTER -> INHIBITOR |
|
||
|
BINDER->LIGAND |
BINDING
|
||
|
SALT/SOLVATE -> PARENT | |||
|
SALT/SOLVATE -> PARENT | |||
|
SALT/SOLVATE -> PARENT |
Related Record | Type | Details | ||
---|---|---|---|---|
|
METABOLITE INACTIVE -> PARENT |
MINOR
|
||
|
METABOLITE INACTIVE -> PARENT | |||
|
METABOLITE ACTIVE -> PARENT |
MAJOR
URINE
|
||
|
METABOLITE INACTIVE -> PARENT | |||
|
METABOLITE ACTIVE -> PARENT |
MAJOR
URINE
|
||
|
METABOLITE INACTIVE -> PARENT |
MINOR
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
||
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
||
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
||
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
||
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
||
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
||
|
IMPURITY -> PARENT |
|
||
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
||
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
||
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
||
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
||
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
||
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (GC)
EP
|
||
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
||
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
||
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |
Name | Property Type | Amount | Referenced Substance | Defining | Parameters | References |
---|---|---|---|---|---|---|
MAXIMUM TOLERATED DOSE | PHARMACOKINETIC |
|
INDICATION BIOLOGICAL PHARMACOKINETIC |
|
||
Biological Half-life | PHARMACOKINETIC |
|
PEDIATRICS PHARMACOKINETIC |
|
||
Cmax | PHARMACOKINETIC |
|
ROUTE OF ADMINSTRATION PHARMACOKINETIC |
|
||
Tmax | PHARMACOKINETIC |
|
FOOD EFFECT PHARMACOKINETIC |
|
||
Volume of Distribution | PHARMACOKINETIC |
|
|
|||